Literature DB >> 17564976

Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Steve E Durham1, David C Samuels, Lynsey M Cree, Patrick F Chinnery.   

Abstract

Mitochondrial DNA (mtDNA) mutations are a common cause of human disease and accumulate as part of normal ageing and in common neurodegenerative disorders. Cells express a biochemical defect only when the proportion of mutated mtDNA exceeds a critical threshold, but it is not clear whether the actual cause of this defect is a loss of wild-type mtDNA, an excess of mutated mtDNA, or a combination of the two. Here, we show that segments of human skeletal muscle fibers harboring two pathogenic mtDNA mutations retain normal cytochrome c oxidase (COX) activity by maintaining a minimum amount of wild-type mtDNA. For these mutations, direct measurements of mutated and wild-type mtDNA molecules within the same skeletal muscle fiber are consistent with the "maintenance of wild type" hypothesis, which predicts that there is nonselective proliferation of mutated and wild-type mtDNA in response to the molecular defect. However, for the m.3243A-->G mutation, a superabundance of wild-type mtDNA was found in many muscle-fiber sections with negligible COX activity, indicating that the pathogenic mechanism for this particular mutation involves interference with the function of the wild-type mtDNA or wild-type gene products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564976      PMCID: PMC1950909          DOI: 10.1086/518901

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree.

Authors:  F Dubeau; N De Stefano; B G Zifkin; D L Arnold; E A Shoubridge
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

Review 2.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 3.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

4.  Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.

Authors:  Angela Pyle; Robert W Taylor; Steve E Durham; Marcus Deschauer; Andrew M Schaefer; David C Samuels; Patrick F Chinnery
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

5.  Mitochondrial DNA copy number threshold in mtDNA depletion myopathy.

Authors:  S E Durham; E Bonilla; D C Samuels; S DiMauro; P F Chinnery
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

6.  A model of the nuclear control of mitochondrial DNA replication.

Authors:  Graham J Capps; David C Samuels; Patrick F Chinnery
Journal:  J Theor Biol       Date:  2003-04-21       Impact factor: 2.691

7.  Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.

Authors:  Karine Auré; Guillemette Fayet; Jean Paul Leroy; Emmanuelle Lacène; Norma Beatriz Romero; Anne Lombès
Journal:  Brain       Date:  2006-03-14       Impact factor: 13.501

8.  Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR.

Authors:  Langping He; Patrick F Chinnery; Steve E Durham; Emma L Blakely; Theresa M Wardell; Gillian M Borthwick; Robert W Taylor; Douglass M Turnbull
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

9.  The length of cytochrome c oxidase-negative segments in muscle fibres in patients with mtDNA myopathy.

Authors:  Joanna L Elson; David C Samuels; Margaret A Johnson; Douglass M Turnbull; Patrick F Chinnery
Journal:  Neuromuscul Disord       Date:  2002-11       Impact factor: 4.296

10.  Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect.

Authors:  Yohei Kirino; Takehiro Yasukawa; Sanna K Marjavaara; Howard T Jacobs; Ian J Holt; Kimitsuna Watanabe; Tsutomu Suzuki
Journal:  Hum Mol Genet       Date:  2006-01-30       Impact factor: 6.150

View more
  34 in total

Review 1.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

2.  Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.

Authors:  Todd Hulgan; Asha R Kallianpur; Yan Guo; Jill S Barnholtz-Sloan; Haley Gittleman; Todd T Brown; Ronald Ellis; Scott Letendre; Robert K Heaton; David C Samuels
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-01       Impact factor: 3.731

3.  Digital PCR Quantitation of Muscle Mitochondrial DNA: Age, Fiber Type, and Mutation-Induced Changes.

Authors:  Allen Herbst; Kevin Widjaja; Beatrice Nguy; Entela B Lushaj; Timothy M Moore; Andrea L Hevener; Debbie McKenzie; Judd M Aiken; Jonathan Wanagat
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053

Review 4.  Control of mitochondrial integrity in ageing and disease.

Authors:  Radek Szklarczyk; Marco Nooteboom; Heinz D Osiewacz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-07-05       Impact factor: 6.237

Review 5.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

6.  Mitochondria: The Retina's Achilles' Heel in AMD.

Authors:  Deborah A Ferrington; M Cristina Kenney; Shari R Atilano; James B Hurley; Emily E Brown; John D Ash
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.

Authors:  Dustin R Masser; Laura Otalora; Nicholas W Clark; Michael T Kinter; Michael H Elliott; Willard M Freeman
Journal:  J Neurochem       Date:  2017-10-20       Impact factor: 5.372

8.  OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.

Authors:  Patrick Yu-Wai-Man; Kamil S Sitarz; David C Samuels; Philip G Griffiths; Amy K Reeve; Laurence A Bindoff; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

9.  Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.

Authors:  Asha R Kallianpur; Mariana Gerschenson; Todd Hulgan; Harpreet Kaur; David B Clifford; David W Haas; Deborah G Murdock; Justin C McArthur; David C Samuels; David M Simpson
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

10.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.